Perioperative Medicine Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Anesthesiology and Critical Care, Hospital la Fe, Valencia, Spain.
BMJ Open. 2024 Oct 29;14(10):e089024. doi: 10.1136/bmjopen-2024-089024.
The rise of opioid-free anaesthesia (OFA) aims to reduce postoperative pain while reducing opioid-related side effects during surgery. However, the various adjuvant agents used in OFA complicate the evaluation of their effectiveness and risks. Recent reviews question the clinical benefits of OFA, highlighting the need for thorough evaluation. This protocol describes a network meta-analysis to compare the effectiveness of OFA with opioid-based anaesthesia and will identify key components for optimal postoperative outcomes.
We will perform a systematic search of literature published in English without time restriction in Embase, The Cochrane Library, MEDLINE (via PubMed) and CINAHL, along with Google Scholar for grey literature. The final search will be performed on 1 October 2024. We will include randomised controlled trials with adult patients undergoing surgery with general anaesthesia, excluding preclinical, observational, regional anaesthesia-only and prolonged anaesthesia outside the operating room studies. The primary outcome is postsurgical pain scores, with secondary outcomes including quality of recovery, opioid consumption, adverse effects and long-term events. We will assess bias using the Cochrane risk of bias 2 tool and conduct Bayesian network meta-analyses for pooled estimates. We will report effect estimates as ORs and standardised mean differences with 95% credible intervals and assess certainty using GRADE methodology.
Ethics approval is not required for this systematic review. Results will be published in a peer-reviewed journal and presented at national and international anaesthesia and pain management conferences.
CRD42024505853.
阿片类药物无麻醉(OFA)的兴起旨在减轻手术期间的术后疼痛,同时减少阿片类药物相关的副作用。然而,OFA 中使用的各种辅助剂使评估其有效性和风险变得复杂。最近的综述质疑 OFA 的临床益处,强调需要进行彻底评估。本方案描述了一项网络荟萃分析,以比较 OFA 与基于阿片类药物的麻醉的有效性,并确定实现最佳术后结果的关键因素。
我们将在没有时间限制的情况下,对 Embase、The Cochrane Library、MEDLINE(通过 PubMed)和 CINAHL 以及 Google Scholar 中的英文文献进行系统检索,以获取灰色文献。最终搜索将于 2024 年 10 月 1 日进行。我们将纳入接受全身麻醉手术的成年患者的随机对照试验,不包括临床前、观察性、仅区域麻醉和手术室外长时间麻醉的研究。主要结局是术后疼痛评分,次要结局包括恢复质量、阿片类药物消耗、不良反应和长期事件。我们将使用 Cochrane 偏倚风险 2 工具评估偏倚,并进行贝叶斯网络荟萃分析以获得汇总估计值。我们将使用 OR 和标准化均数差以及 95%可信区间报告效应估计值,并使用 GRADE 方法评估确定性。
本系统评价不需要伦理批准。结果将发表在同行评议的期刊上,并在国内和国际麻醉和疼痛管理会议上进行报告。
PROSPERO 注册号:CRD42024505853。